Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

Diabetes Care

Volumn 14, Issue 3, 1991, Pages 173-194

  DeFronzo, Ralph A ^a   Ferrannini, Eleuterio ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGED; FEMALE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; REVIEW;

ARTERIOSCLEROSIS; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN RESISTANCE; OBESITY; SYNDROME;

EID: 0026021161     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.14.3.173     Document Type: Article

References (307)

1. Modan M, Halkin H, Almog S, Lusky A, Eskol A, Shefi M, Shitrit A, Fuchs I: Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 75:809-17, 1985
2. Kannel WB, Neaton JD, Wentworth D, Thomas HE, Stamler J, Hulley SB, Kjelsberg MO: Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Am Heart J 112:825-36, 1986
3. Harris MI, Hadden WC, Knowler WC, Bennett PH: Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes 36:523-34, 1987
4. Stern M, Haffner SM: Type II diabetes and its complications in Mexican Americans. Diabetes Metab Rev 6:29-46, 1990
5. Knowler WC, Pettitt DJ, Saad MF, Bennett PH: Diabetes mellitus in the Pima Indians: incidence, risk factors, and pathogenesis. Diabetes Metab Rev 6:1-28, 1990
6. Stout RW: Insulin and atheroma - an update. Lancet 1:1077-79, 1987
7. Carlson LA, Bottiger LE, Anfeldt PE: Risk factors for myocardial infarction in the Stockholm prospective study: a 14 year follow-up focusing on the role of plasma triglycerides and cholesterol. Acta Med Scand 206:351-60, 1979
8. Castelli WP, Garrison RJ, Wilson WF, Abbott RD, Kalousdian S, Kannel WB: Lipoprotein cholesterol: incidence of coronary heart disease and lipoprotein cholesterol levels. JAMA 256:2835-38, 1986
9. Stamler J, Wentworth D, Neaton JD: Serum cholesterol: is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? JAMA 256:2823-28, 1986
10. Sims EAH, Danford E, Horton ES, Bray CA, Glennon JA, Salans LB: Endocrine and metabolic effects of experimental obesity in man. Recent Prog Horm Res 29:457-96, 1973
11. DeFronzo RA, Tobin JD, Andres R: The glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 6:E214-23, 1979
12. DeFronzo RA, Sherwin RS, Hendler R, Felig P: Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding. J Clin Invest 62:204-13, 1978
13. Bonadonna R, Groop L, Kraemer N, DeFronzo RA: Obesity and insulin resistance in man: a dose response study. Metabolism 39:452-59, 1990
14. Golay A, Felber JP, Jequier E, DeFronzo RA, Ferrannini E: Metabolic basis of obesity and non-insulin dependent diabetes mellitus. Diabetes Metab Rev 4:727-47, 1988
15. Kolterman OG, Insel J, Saekow M, Olefsky JM: Mechanism of insulin resistance in human obesity: evidence for receptor and post-receptor defects. J Clin Invest 65:1273-84, 1980
16. Bogardus C, Lillioja S, Mott D, Reaven GR, Kashiwagi A, Foley J: Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in Pima Indians. J Clin Invest 73:800-805, 1984
17. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP: The effect of insulin on the disposal of intravenous glucose: results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30:1000-1007, 1981
18. DeFronzo RA: Lilly lecture 1987: the triumvirate: β-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 37:667-87, 1988
19. Felber J-P, Ferrannini E, Golay A, Meyer HU, Theibaud D, Curchod B, Maeder E, Jequier E, DeFronzo RA: Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 36:1341-50, 1987
20. Saad F, Knowler C, Pettitt J, Nelson G, Mott M, Bennet H: Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes. Lancet 1:1356-59, 1989
21. Reaven GM, Hollenbeck CB, Chen Y-DI: Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance. Diabetologia 32:52-55, 1989
22. Bodkin NL, Metzger BL, Hansen BC: Hepatic glucose production and insulin sensitivity preceding diabetes in monkeys. Am J Physiol 256:E676-81, 1989
23. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK: Increased insulin concentrations in nondiabetic offspring of diabetic parents. N Engl J Med 319:1297-301, 1988
24. Balkau B, King H, Zimmet P, Raper LR: Factors associated with development of diabetes in the Micronesian population of Nauru. Am J Epidemiol 122:594-605, 1985
25. Felber JP, Jallut D, Golay A, Munger R, Frascarolo P, Jequier E: Obesity to diabetes: a longitudinal study of glucose metabolism in man (Abstract). Diabetes 38 (Suppl. 1):221A, 1989
26. DeFronzo RA, Diebert D, Hendler R, Felig P: Insulin sensitivity and insulin binding in maturity onset diabetes. J Clin Invest 63:939-46, 1979
27. DeFronzo RA, Simonson D, Ferrannini E: Hepatic and peripheral insulin resistance: a common feature of insulin-independent and insulin-dependent diabetes. Diabetologia 23:313-19, 1982
28. Golay A, DeFronzo RA, Ferrannini E, Simonson DC, Thorin D, Acheson K, Thiebaud D, Curchod B, Jequier E, Felber JB: Oxidative and non-oxidative glucose metabolism in non-obese type 2 (non-insulin-dependent) diabetic patients. Diabetologia 31:585-91, 1988
29. Hollenbeck CB, Chen Y-DI, Reaven GM: A comparison of the relative effects of obesity and non-insulin-dependent diabetes mellitus on in vivo insulin-stimulated glucose utilization. Diabetes 33:622-26, 1984
30. Kolterman OG, Gray RS, Griffin J, Burstein P, Insel J, Scarlett JA, Olefsky JM: Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. J Clin Invest 68:957-69, 1981
31. Barnett AH, Eff C, Leslie RD, Pyke DA: Diabetes in identical twins: a study of 200 pairs. Diabetologia 20:87-93, 1981
32. Leslie RDF, Pyke DA: Genetics of diabetes. In Diabetes Annual/3. Alberti KGMM, Krall LP, Eds. Amsterdam, Elsevier, 1987, p. 39-54
33. Newman B, Selby JV, King MC, Slemenda C, Fabisitz R, Friedman GD: Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 30:763-68, 1987
34. Kobberling J, Tillil H: Empirical risk figures for first-degree relatives of non-insulin-dependent diabetics. In The Genetics of Diabetes Mellitus. Kobberling J, Tattersal R, Eds. London, Academic, 1982, p. 201-10
35. Eriksson J, Franssila-Kallunki A, Edstrand A, Saloranta C, Widen E, Schalin C, Groop L: Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321:337-43, 1989
36. DeFronzo RA, Simonson DC, Ferrannini E: Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387-95, 1989
37. Stamler R, Stamler J, Reidlinger WF, Algera G, Roberts RH: Weight and blood pressure: findings in hypertension screening of 1 million Americans. JAMA 240:1607-10, 1978
38. Havlik RJ, Hubert HB, Fabsitz RR, Feinleib M: Weight and hypertension. Ann Intern Med 98:855-59, 1983
39. Butler WJ, Ostrander LD, Carman WJ, Lamphiear DE: Diabetes mellitus in Tecumseh, Michigan: prevalence, incidence and associated conditions. Am J Epidemiol 116:971-80, 1982
40. Jarrett RJ, Keen H, McCartney M, Fuller JH, Hamilton PJS, Reid DD, Rose G: Glucose tolerance and blood pressure in two population samples: their relation to diabetes mellitus and hypertension, Int J Epidemiol 7:15-24, 1978
41. Turner RC: United Kingdom prospective diabetes study. III. Prevalence of hypertension and hypotensive therapy in patients with newly diagnosed diabetes. Hypertension 7 (Suppl. II):8-13, 1985
42. Tuck ML, Sowers J, Dornfeld L, Kledzik G, Maxwell M: The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med 304:930-33, 1981
43. MacMahon SW, MacDonald GJ, Bernstein L, Andrews G, Blacket RB: Comparisons of weight reduction with metoprolol in treatment of hypertension in young over-weight patients. Lancet 1:1233-36, 1985
44. Sowers JR, Nyby M, Stern N, Beck F, Baron S, Catania R, Vlachis N: Blood pressure and hormone changes associated with weight reduction in the obese. Hypertension 4:686-91, 1982
45. Reisin E, Abel R, Modan M, Silverberg DS, Eliahou HE, Modan B: Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Med 298:1-6, 1978
46. Sonne-Holm S, Sorensen TIA, Jensen G, Schnohr P: Independent effects of weight change and attained body weight on prevalence of arterial hypertension in obese and non-obese men. Br Med J 299:767-70, 1980
47. Horton ES: The role of exercise in the treatment of hypertension in obesity, Int J Obes 5 (Suppl. I): 165-71, 1981
48. Krotkiewski M, Mandroukas K, Sjostrom L, Sullivan L, Wetterqvist H, Bjorntorp P: Effects of long-term physical training on body fat, metabolism, and blood pressure in obesity. Metabolism 28:650-58, 1979
49. Andrews G, MacMahon SW, Austin A, Byrne DG: Hypertension: comparison of drug and non-drug treatments. Br Med J 284:1523-26, 1982
50. Maiorano G, Contursi V, Saracino E, Ricapito M: Physical exercise and hypertension. New insights and clinical implications. Am J Hypertens 2 (Suppl.):60-64S, 1989
51. Henry RR, Wallace P, Olefsky JM: Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus. Diabetes 35:990-98, 1986
52. DeFronzo RA: Insulin secretion, insulin resistance, and obesity, Int J Obes 6 (Suppl. 1):72-82, 1982
53. DeFronzo RA, Sherwin RS, Kraemer N: Effect of physical training on insulin action in obesity. Diabetes 36:1379-85, 1987
54. Koivisto V, DeFronzo RA: Exercise in the treatment of type II diabetes. Acta Endocrinol Suppl 262:107-11, 1984
55. Schneider SH, Vitug A, Ruderman SV: Atherosclerosis and physical activity. Diabetes Metab Rev 1:513-53, 1986
56. Horton ES: Exercise and physical training: effect on insulin sensitivity and glucose metabolism. Diabetes Metab Rev 2:1-17, 1986
57. Haffner SM, Fong D, Hazuda HP, Pugh JA, Patterson JK: Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics. Metabolism 37: 338-45, 1988
58. Fournier AM, Gadia MT, Kubrusly DV, Skyler J, Sosenko JM: Blood pressure, insulin and glycemia in non-diabetic subjects. Am J Med 80:861-64, 1986
59. Singer P, Godicke W, Voigt S, Hajdu I, Weiss M: Postprandial hyperinsulinemia in patients with mild essential hypertension. Hypertension 7:182-86, 1985
60. Lucas CP, Estigarribia JA, Darga LL, Reaven CM: Insulin and blood pressure in obesity. Hypertension 7:702-706, 1985
61. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, Bonati PA, Bergonzani M, Gnudi L, Passeri M, Reaven G: Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320:703-706, 1989
62. Bonora E, Zavaroni I, Pezzarossa A, Alpi O, Brushi F, Dall'Aglio E, Guerra L, Coscelli C, Butturini U: Relationship between blood pressure and plasma insulin in nonobese and obese nondiabetic subjects. Diabetologia 30:719-23, 1987
63. Christlieb AR, Krolewski AS, Warram JH, Soeldner JS: Is insulin the link between hypertension and obesity? Hypertension 7 (Suppl. II):54-57, 1985
64. Manicardi V, Camellini L, Bellodi G, Coscelli C, Ferrannini E: Evidence for an association of high blood pressure and hyperinsulinemia in obese man. J Clin Endocrinol Metab 62:1302-304, 1986
65. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S: Insulin resistance in essential hypertension N Engl J Med 317:350-57, 1987
66. Pollare T, Lithell H, Berne C: Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 39:167-74, 1990
67. Dustan HP: Mechanisms of hypertension associated with obesity. Ann Intern Med 98:860-64, 1983
68. Mujais SK, Tarazi RC, Dustan HP, Fouad FM, Bravo EL: Hypertension in obese patients: hemodynamic and volume studies. Hypertension 4:84-92, 1982
69. Frohlich ED: Mechanisms contributing to high blood pressure. Ann Intern Med 98:709-14, 1983
70. Wiedmann P, Beretta-Piccoli C, Trost BN: Pressor factors and responsiveness in hypertension accompanying diabetes mellitus. Hypertension 7 (Suppl. II):32-42, 1985
71. Feldt-Rasmussen B, Mathiesen ER, Deckert T, Fiese J, Christensen NJ, Bent-Hansen L, Nielsen MD: Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type I (insulin-dependent) diabetes mellitus. Diabetologia 30:610-17, 1987
72. DeFronzo RA: The effect of insulin on renal sodium metabolism. Diabetologia 21:165-71, 1981
73. O'Hare JA, Ferriss JB, Brady D, Twomey B, O'Sullivan J: Exchangeable sodium and renin in hypertensive diabetic patients with and without nephropathy. Hypertension 7 (Suppl. II):43-48, 1985
74. DeFronzo RA: Insulin and renal sodium handling: clinical implications. Int J Obes 5 (Suppl. 1):93-104, 1981
75. Dahl LK: Salt and hypertension. Am J Clin Nutr 25:231-44, 1972
76. Fletcher A: The effect of weight reduction upon the blood pressure of obese hypertensive women. Q J Med 23:331-45, 1954
77. Kolanowski J, deGasparo M, Desmecht P, Crabbe J: Further evaluation of the role of insulin in sodium retention associated with carbohydrate administration after a fast in the obese. Eur J Clin Invest 2:439-44, 1972
78. Hoffman RS, Martino JA, Wahl G, Arky R: Effects of fasting and refeeding. II. Tubular sites of sodium reabsorption and effects of oral carbohydrate on potassium, calcium, and phosphate excretion. J Lab Clin Med 74:915-26, 1960
79. Kolanowski J: Influence of insulin and glucagon on sodium balance in obese subjects during fasting and refeeding. Int J Obes 5 (Suppl. 1): 105-14, 1981
80. DeFronzo RA, Cooke CR, Andres R, Faloona CR, Davis PJ: The effect of insulin on renal handling of sodium, potassium, calcium and phosphate in man. J Clin Invest 55:845-55, 1975
81. Skott P, Hother-Nielsen O, Bruun NE, Giese J, Nielsen MD, Beck-Nielsen H, Parving HH: Effects of insulin on kidney function and sodium excretion in healthy subjects. Diabetologia 32:694-99, 1989
82. DeFronzo RA, Goldberg M, Agus ZS: The effects of glucose and insulin on renal electrolyte transport. J Clin Invest 58:83-90, 1976
83. Baum M: Insulin stimulates volume absorption in the rabbit proximal convoluted tubule. J Clin Invest 79: 1104-109, 1987
84. Rocchini AP, Katch V, Kveselis D, Moorehead C, Martin MN, Lampman R, Gregory M: Insulin and renal sodium retention in obese adolescents. Hypertension 14:367-74, 1989
85. DeHaven J, Sherwin R, Hendler R, Felig P: Nitrogen and sodium balance and sympathetic nervous system activity in obese subjects treated with a low-calorie protein or mixed diet. N Engl J Med 302:477-82, 1980
86. O'Dea K, Esler M, Leonard P, Stockigt JR, Nestel P: Noradrenaline turnover during under- and over-eating in normal weight subjects. Metabolism 31:896-99, 1982
87. Rappaport EB, Young JB, Landsberg L: Initiation, duration and dissipation of diet-induced changes in sympathetic nervous system activity in the rat. Metabolism 31:143-46, 1982
88. Young JB, Landsberg L: Suppression of sympathetic nervous system during fasting. Science 196:1473-75, 1977
89. Young JB, Landsberg L: Stimulation of the sympathetic nervous system during sucrose feeding. Nature (Lond) 269:615-17, 1977
90. Landsberg L, Dreiger DR: Obesity, metabolism, and the sympathetic nervous system. Am J Hypertens 2:125S-132S, 1989
91. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L: Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 30:219-25, 1981
92. Liang C, Doherty JU, Faillace R, Maekawa K, Arnold S, Gavras H, Hood WB: Insulin infusion in conscious dogs: effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines. J Clin Invest 69:1321-36, 1982
93. Pereda SA, Eckstein JW, Abbound FM: Cardiovascular responses to insulin in the absence of hypoglycemia. Am J Physiol 202:249-52, 1962
94. Young JB, Cohen WR, Rappaport EB, Landsberg L: High plasma norepinephrine concentrations at birth in infants of diabetic mothers. Diabetes 28:697-99, 1979
95. Anderson EA, Sinkey CA, Lawton WJ, Mark AL: Elevated sympathetic nerve activity in borderline hypertensive humans: evidence from direct intraneural recordings. Hypertension 14:177-83, 1989
96. Young JB: Effect of experimental hyperinsulinemia on sympathetic nervous system activity in the rat. Life Sci 43:193-200, 1988
97. Landsberg L, Young JB: Insulin-mediated glucose metabolism in the relationship between dietary intake and sympathetic nervous system activity. Int J Obes 9 (Suppl. 2):63-68, 1985
98. Landsberg L, Young JB: Diet and sympathetic nervous system: relationship to hypertension, Int J Obes 5 (Suppl. 1):79-91, 1981
99. Elser M, Jennings G, Korner P, Willett I, Dudley F, Haskin C, Anderson W, Lambert G: Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 11:3-20, 1988
100. Diebert DC, DeFronzo RA: Epinephrine-induced insulin resistance in man: a beta receptor mediated phenomenon. J Clin Invest 65:717-21, 1980
101. Clutter WE, Rizza RA, Gerich JE, Cryer PE: Regulation of glucose metabolism by sympathochromaffin catecholamines. Diabetes Metab Rev 1:1-15, 1988
102. Kahn CR, Crettaz M: Insulin receptors and the molecular mechanism of insulin action. Diabetes Metab Rev 1:5-32, 1985
103. Czech MP: Second messengers. In Handbook of Diabetes. Brownlee M, Ed. New York, Garland, 1981, p. 117-50
104. Saltiel AR: Second messengers of insulin action. Diabetes Care 13:244-56, 1990
105. Kasuga M, Fujita-Yamaguchi Y, Blithe DL, Kahn CR: Tyrosine specific protein kinase activity is associated with the purified insulin receptor. Proc Natl Acad Sci USA 80:2137-41, 1983
106. Rosen OM: Banting lecture 1989: structure and function of insulin receptors. Diabetes 38:1508-11, 1989
107. Kahn B, Cushman SW: Subcellular translocation of glucose transporters: role in insulin action and its perturbation in altered metabolic states. Diabetes Metab Rev 1:203-28, 1985
108. Garvey WT, Kolterman OG: Correlation of in vivo and in vitro actions of insulin in obesity and non-insulin dependent diabetes mellitus: role of the glucose transport system. Diabetes Metab Rev 4:543-69, 1988
109. Garvey WT: Insulin resistance and non-insulin dependent diabetes mellitus: which horse is pulling the cart? Diabetes Metab Rev 5:727-44, 1989
110. Foley JE: Mechanisms of impaired insulin action in isolated adipocytes from obese and diabetic subjects. Diabetes Metab Rev 4:487-505, 1988
111. Fink RI, Wallace P, Olefsky JM: Effects of aging on glucose-mediated glucose disposal and glucose transport. 77:2034-41, 1986
112. Reaven GM, Chang H, Hoffman BB, Azhar S: Resistance to insulin-stimulated glucose uptake in adipocytes isolated from spontaneously hypertensive rats. Diabetes 38:1155-60, 1989
113. Caro JF, Dohm LG, Pories WJ, Sinha MK: Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and type II diabetes. Diabetes Metab Rev 5:665-91, 1989
114. Lillioja S, Bogardus C: Obesity and insulin resistance: lessons learned from the Pima Indians. Diabetes Metab Rev 4:515-40, 1988
115. Blaustein MP: Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. Am J Physiol 232:C165-73, 1977
116. Bruner HR, Change P, Wallach R, Sealey JE, Laragh JH: Angiotensin II vascular receptors: their avidity in relationship to sodium balance, the autonomic nervous system, and hypertension. J Clin Invest 51:58-67, 1972
117. Ma TS, Bose D: Sodium in smooth muscle relaxation. Am J Physiol 232:C59-66, 1977
118. Hermsmeyer RK: Vascular muscle membrane cation mechanisms and total peripheral resistance. Hypertension 10 (Suppl. 1):20-22, 1987
119. Tobian L, Binion JT: Tissue cations and water in arterial hypertension. Circulation 5:754-58, 1952
120. Bohr DR, Seider C, Sobieski J: Possible role of sodiumcalcium pumps in tension development of vascular smooth muscle. Microvasc Res 1:335-43, 1969
121. Dominiczak AF, Bohr DF: Vascular smooth muscle in hypertension. J Hypertens Suppl 7:5107-15, 1989
122. + transport in skeletal muscle. Physiol Rev 66:542-80, 1986
123. Clausen T, Everts ME: Regulation of the Na, K pump in skeletal muscle. Kidney Int 35:1-13, 1989
124. The Sodium Pump. Proc 5th Int Conf Na,K ATPase. Skou JC, Norby JG, Maunsbach AB, Esmann M, Eds. New York, Liss, 1988
125. Davidson JS, Opie LH, Keding B: Sodium-potassium cotransport activity as genetic marker in essential hypertension. Br Med J 284:539-41, 1982
126. + cellular metabolism. Clin Sci 61:181-86, 1981
127. Boon NA, Harper C, Aronson JK, Grahame-Smith DG: Cation transport functions in vitro in patients with untreated essential hypertension: a comparison of erythrocytes and leukocytes, Clin Sci 68:511-15, 1985
128. Postnov YV, Orlov SN: Ion transport across plasma membranes in primary hypertension. Physiol Rev 65: 904-45, 1985
129. Davidson JD, Opie LH, Keding B: Sodium-potassium cotransport activity as genetic marker in essential hypertension. Br Med J 284:539-41, 1982
130. Trevisan M, Ostrow D, Cooper R, Liu K, Sparks S, Okonek A, Stevens E, Marquardt J, Stamler J: Abnormal red blood cell ion transport and hypertension: the People's Gas Company Study. Hypertension 5:363-67, 1983
131. Canessa M, Spalvins A, Adragna N, Falkner B: Red cell sodium countertransport and cotransport in normotensive and hypertensive blacks. Hypertension 6:344-51, 1984
132. + cotransport system in erythrocytes from essential hypertensive patients. Nature (Lond) 284:281-83, 1980
133. Hilton PJ: Cellular sodium transport in essential hypertension. N Engl J Med 314:229, 1986
134. Blaustein MP, Hamlyn JM: Role of a natriuretic factor in essential hypertension: an hypothesis. Ann Intern Med 98:785-92, 1983
135. De Luise M, Blackman GL, Flier JS: Reduced activity of the red-cell sodium-potassium pump in human obesity. N Engl J Med 303:1017-22, 1980
136. Simat BM, Mayrand RR, From AHL, Morley JE, Billington C, Fullerston DS, Ahmed K: Is the erythrocyte sodium pump altered in human obesity? J Clin Endocrinol Metab 56:925-29, 1983
137. Rahmani-Jourdheuil D, Mourayre Y, Vague P, Boyer J, Juhan-Vague I: In vivo insulin effect on ATPase activities in erythrocyte membrane from insulin-dependent diabetes. Diabetes 36:991-95, 1987
138. Cohen MP, Dasmahapatra A, Shapiro E: Reduced glomerular sodium/potassium adenosine-triphosphatase activity in acute streptozocin diabetes and its prevention by oral sorbinil. Diabetes 34:1071-74, 1985
139. DeFronzo RA: Obesity is associated with impaired insulin-mediated potassium uptake. Metabolism 37:105-108, 1988
140. Zierler KL, Rabinowitz D: Effect of very small concentrations of insulin on forearm metabolism: persistence of its action on potassium and free fatty acids without its effect on glucose. J Clin Invest 43:950-60, 1964
141. DeFronzo RA: Regulation of extrarenal potassium homeostasis by insulin and catecholamines. Curr Top Membr Transp 28:299-329, 1987
142. Zierler KL: Effect of insulin on potassium efflux from rat muscle in the presence and absence of glucose. Am J Physiol 198:1066-70, 1968
143. Ferrannini E, Taddei S, Santoro D, Natali A, Boni C, DelChiaro D, Buzzogoli G: Independent stimulation of glucose metabolism and Na/K exchange by insulin in the human forearm. Am J Physiol 255:E953-58, 1988
144. DeFronzo RA, Ferrannini E, Hendler R, Felig P, Wahren J: Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes 32:35-45, 1983
145. DeFronzo RA, Felig P, Ferrannini E, Wahren J: The effect of graded doses of insulin on splanchnic and peripheral potassium metabolism in man. Am J Physiol 238:E421-27, 1980
146. Aronson PS: Red cell sodium-lithium countertransport and essential hypertension. N Engl J Med 307:317-21, 1982
147. Mahnensmith RL, Aronson PS: The plasma membrane sodium-hydrogen exchanger and its role in physiological and pathophysiological process. Circ Res 56:773-88, 1985
148. - cotransport systems in essential hypertension. Hypertension 10 (Suppl. I):4-10, 1987
149. Moore RD: Stimulation of Na:H exchange by insulin. Biophys J 33:203-10, 1981
150. Moore RD, Fidelman ML, Seeholzer SH: Correlation between insulin action upon glycolysis and change in intracellular pH. Biochem Biophys Res Commun 1:905-10, 1979
151. Moore RD, Gupta RK: Effect of insulin on intracellular pH as observed by phosphorus-31, NMR spectroscopy. Int J Quantum Chem Symp 7:83-92, 1986
152. Moore RD: Stimulation of Na:H exchange by insulin. Biophys J 33:203-10, 1981
153. Putnam RW: Effect of insulin on intracellular pH in frog skeletal muscle fibers. Am J Physiol 248:C330-36, 1985
154. Mukherjee SP, Mukherjee C: Metabolic activation of adipocytes by insulin accompanied by an early increase in intracellular pH. Ann NY Acad Sci 372:347-51, 1981
155. Tillman DM, Semple PF: Calcium and magnesium in essential hypertension. Clin Sci 75:395-402, 1988
156. 2+ modulation in genetic hypertension. Hypertension 14:145-51, 1989
157. Aickin CC: Intracellular pH regulation by vertebrate muscle. Annu Rev Physiol 48:346-61, 1986
158. Boron WF: Intracellular pH regulation in epithelial cells. Annu Rev Physiol 48:377-88, 1986
159. Mulvany MJ: Pathohysiology of vascular smooth muscle in hypertension. J Hypertens 2 (Suppl. III):413-20, 1984
160. Lever AF: Slow pressor mechanisms in hypertension: a role for hypertrophy of resistance vessels? J Hypertens 4:515-24, 1986
161. Wray S: Smooth muscle intracellular pH: measurement, regulation, and function. Am J Physiol 254:C213-25, 1988
162. + antiport activity in human hypertension. J. Hypertens 7:471-75, 1989
163. Moolenaar WH: Effects of growth factors on intracellular pH regulation. Annu Rev Physiol 48:2363-76, 1986
164. Berk BC, Brock JA, Webb RC, Taubman MB, Atkinson WJ, Gimbrone MA, Alexander RW: Epidermal growth factor, a vascular smooth muscle mitogen, induces rat aortic contraction. J Clin Invest 75:1083-86, 1985
165. + exchange in cultured vascular smooth muscle cells. J Biol Chem 262:5057-64, 1987
166. Lyall F, Morton JJ, Lever AF: Angiotensin II activates Na/ H exchange and stimulates growth in cultured vascular smooth muscle cells (Abstract). Clin Sci 74 (Suppl. 18):45P, 1988
167. Kleinman KS, Fine LG: Prognostic implications of renal hypertrophy in diabetes mellitus. Diabetes Metab Rev 4:179-89, 1988
168. Woods JW, Falk RJ, Pittman AW, Klemmer PJ, Watson BS, Nambodiri K: Increased red-cell sodium-lithium countertransport in normotensive sons of hypertensive parents. N Engl J Med 306:593-95, 1982
169. Williams RR, Hunt SC, Huida H, Smith JB, Ash KO: Sodium-lithium countertransport in erythrocytes of hypertension prone families in Utah. Am J Epidemiol 11:338-44, 1983
170. Canessa M: The polymorphism of red cell Na and K transport in essential hypertension: findings, controversies, and perspectives. In Erythrocyte Membranes. Vol. 3. New York, Liss, 1984, p. 293-315
171. Williams RR: Will gene markers predict hypertension? Hypertension 14:610-13, 1989
172. Camussi A, Bianchi G: Genetics of essential hypertension: from the unimodal-bimodal controversy to molecular technology. Hypertension 12:620-28, 1988
173. Canessa M, Adranga N, Solomon HS, Connolly TM, Tosteson DC: Increased sodium-lithium countertransport in red cells of patients with essential hypertension. N Engl J Med 302:772-76, 1980
174. Adragna NC, Canessa ML, Solomon H, Slater E, Tosteson DC: Red cell lithium-sodium countertransport and sodium-potassium cotransport in patients with essential hypertension. Hypertension 4:795-804, 1982
175. Weder AB: Red cell lithium-sodium countertransport and renal lithium clearance in hypertension. N Engl J Med 314:198-201, 1985
176. + exchange and other ion-transport systems in erythrocytes of essential hypertensives and spontaneously hypertensive rats: a comparative analysis. J Hypertens 7:781-88, 1989
177. Livne A, Veitch R, Grinstein S, Balfe JW, Marquez-Julio A, Rothstein A: Increased platelet Na-H exchange rates in essential hypertension: application of a novel test. Lancet 1:533-36, 1987
178. Schmouder RL, Weder AB: Platelet sodium-proton exchange is increased in essential hypertension. J Hypertens 7:325-30, 1989
179. Resnick LM: Calcium metabolism in the pathophysiology and treatment of clinical hypertension. Am J Hypertens 2:1795-855, 1989
180. Linder A, Hinds RT, Vincenjo FF: Elevated free calcium in red blood cells of essential hypertensives: preliminary findings with Fluo-3, a new fluorescent probe (Abstract). In Proc Am Soc Nephrol, 1989, Washington, DC, p. 2024
181. Mangili R, Bending JJ, Scott G, Li LK, Gupta A, Viberti GC: Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy. N Engl J Med 318:146-50, 1988
182. Stout RW: Insulin and atheroma: 20-yr perspective. Diabetes Care 13:631-54, 1990
183. King GL, Goodman D, Buzney S, Moses A, Kahn CR: Receptors and growth promoting effects of insulin and insulin like growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest 75:1028-36, 1985
184. Banskota NK, Taub R, Zellner K, Olsen P, King GL: Characterization of induction of protooncogene c-myc and cellular growth in human vascular smooth muscle cells by insulin and IGF-I. Diabetes 38:123-29, 1989
185. Pfeifle B, Ditschuneit H: Effect of insulin on the growth of cultured arterial smooth muscle cells. Diabetologia 20:155-58, 1981
186. Jaub R, Roy A, Dietes R, Koontz J: Insulin as a growth factor in rat hepatoma cells: stimulation of proto-oncogene expression. J Biol Chem 262:10893-97, 1987
187. Froesch ER, Schmid C, Schwander J, Zapf J: Actions of insulin-like growth factors. Annu Rev Physiol 47:443-67, 1985
188. Sinha MK, Buchanan C, Leggett N, Martin L, Khazanie PG, Dimarchi R, Pories WJ, Caro JF: Mechanisms of IGF-I-stimulated glucose transport in human adipocytes: demonstration of specific IGF-I receptors not involved in stimulation of glucose transport. Diabetes 38:1217-25, 1989
189. Salamon EA, Luo J, Murphy LJ: The effect of acute and chronic insulin administration on insulin-like growth factor-I expression in the pituitary-intact and hypophysectomised rat. Diabetologia 32:348-53, 1989
190. Folkow B: Cardiovascular structural adaptation: its role in the inhibition and maintenance of primary hypertension: Volhard lecture. Clin Sci 55:3s-22s, 1978
191. Mulvany MJ, Hansen PK, Aalkjaer C: Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res 43:854-64, 1978
192. Brayden JE, Halpern W, Brann LR: Biochemical and mechanical properties of resistance arteries from normotensive and hypertensive rats. Hypertension 5:17-25, 1983
193. Ooshima A, Fuller GC, Cardinale GJ, Spector S, Udenfriend S: Increased collagen synthesis in blood vessels of hypertensive rats and its reversal by antihypertensive agents. Proc Natl Acad Sci USA 71:3019-23, 1974
194. Kaiser N, Tur-Sinai A, Hasin M, Cerasi E: Binding, degradation and biological activity of insulin in vascular smooth muscle cells. Am J Physiol 249:E292-98, 1985
195. Cruz AB, Amatuzio DS, Grande F, Hay LJ: Effect of intraarterial insulin on tissue cholesterol and fatty acids in alloxan-diabetic dogs. Circ Res 9:39-43, 1961
196. Reaven GM: Banting lecture 1988: role of insulin resistance in human disease. Diabetes 37:1595-607, 1988
197. Ginsberg HN: Very low density lipoprotein metabolism in diabetes mellitus. Diabetes Metab Rev 2:571-89, 1987
198. Kissebah AH: Low density lipoprotein metabolism in non-insulin dependent diabetes mellitus. Diabetes Metab Rev 3:619-51, 1987
199. Chen Y-DI, Jeng C-Y, Reaven GM: HDL metabolism in diabetes. Diabetes Metab Rev 3:653-68, 1987
200. Jarrett RJ: Cardiovascular disease and hypertension in diabetes mellitus. Diabetes Metab Rev 5:547-58, 1990
201. Dunn FL: Hyperlipidemia in diabetes mellitus. Diabetes Metab Rev 6:47-61, 1990
202. Pyorala K, Laakso M, Vusitupa M: Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 3:463-524, 1987
203. Castelli WP, Doyle JR, Gordon TR, Hames CB, Hjortland MC, Hulley SB, Kagan A, Zukel WJ: HDL cholesterol and other lipids in coronary heart disease: the cooperative lipoprotein phenotyping study. Circulation 55: 767-72, 1977
204. Miller NE, Forde OH, Thelle DS, Mjos OD: The Tromso heart study: high density lipoprotein and coronary heart disease: a prospective case-control study. Lancet 1:965-67, 1977
205. Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB: Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham study. JAMA 256:2835-38, 1986
206. Grundy SM: Cholesterol and coronary heart disease: a new era. JAMA 256:2849-58, 1986
207. Kannel WB: Status of risk factors and their consideration in antihypertensive therapy. Am J Cardiol 59:80-90A, 1987
208. Kannel WB: Lipids, diabetes, and coronary heart disease: insights from the Framingham study. Am Heart J 110:1100-107, 1985
209. Lipid Research Clinics Program: The lipid research clinics coronary primary prevention trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 251:365-74, 1984
210. Grundy SM: Cholesterol and coronary disease. JAMA 256:2849-58, 1986
211. Levy RI: Primary prevention of coronary heart disease by lowering lipids: results and implications. Am Heart J 110:1116-22, 1985
212. Anderson KM, Castelli WP, Levy D: Cholesterol and mortality: 30 years of follow-up from the Framingham study. JAMA 257:2176-80, 1987
213. Frick MH, Elo O, Kauko H, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koshinen P, Manninen V, Maenpaa H, Malkonen M, Manttari M, Norola S, Pasternack A, Pikkarainen J, Romo M, Sjoblom T, Nikkila EA: Helsinki heart study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia. N Engl J Med 317:1237-45, 1987
214. Aberg H, Lithell H, Selinius I, Hedstrand H: Serum triglycerides are a risk factor for myocardial infarction but not for angina pectoris: results from a 10-year follow-up of Uppsala primary prevention study. Atherosclerosis 54:89-97, 1985
215. Carlson LA, Bottiger LE: Risk factors for ischaemic heart disease in men and women: results of the 19-year follow-up of the Stockholm prospective study. Acta Med Scand 218:207-11, 1985
216. Castelli WP: The triglyceride issue: a view from Framingham. Am Heart J 112:432-37, 1986
217. Grundy SM, Barrett-Conner E, Bierman EL, Clarkson TB, Harlan WR, Hazzard WH, Hunninghake DB, Maquson DT, O'Keefe G, Rifkin H, Spector AA, Winston N, Wood PD: Treatment of hypertriglyceridemia: NIH consensus development conference summary. Arteriosclerosis 4:296-301, 1984
218. Cambien F, Jaqcqueson A, Richard JL, Warnet JM, Ducimetiere P, Claude JR: Is the level of serum triglyceride a significant predictor of coronary death in "normocholesterolemic" subjects? The Paris prospective study. Am J Epidemiol 124:624-32, 1986
219. Steiner GF, Vranic M: Hyperinsulinemia and hypertriglyceridemia, a vicious cycle with atherogenic potential. Int J Obes 6 (Suppl. 1):117-24, 1982
220. Fontbonne A, Eschwege E, Cambien F, Richard JL, Ducimetiere P, Thibult N, Warnet JM, Claude JR, Rosselin GE: Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Diabetologia 32:300-304, 1989
221. Greenfield M, Kolerman O, Olefsky J, Reaven G: Mechanism of hypertriglyceridemia in diabetic patients with fasting hyperglycemia. Diabetologia 18:441-46, 1980
222. Schwandt P: Very low density lipoproteins in type II diabetes mellitus and risk of atherosclerosis. Horm Metab Res 15:83-87, 1985
223. Ginsberg H, Grundy SM: Very low density lipoprotein metabolism in non-ketotic diabetes mellitus: effect of dietary restriction. Diabetologia 23:421-25, 1982
224. Brewer HB, Gregg RE, Hoeg JM, Fojo SS: Apolipoproteins and lipoproteins in human plasma: an overview. Clin Chem 33:B4-8, 1988
225. Schaefer EJ, Levy RI: Pathogenesis and management of lipoprotein disorders. N Engl J Med 312:1300-10, 1985
226. Olefsky JM, Farquhar JW, Reaven GM: Reappraisal of the role of insulin in hypertriglyceridemia. Am J Med 57:551-60, 1974
227. Tobey TA, Greenfield M, Kraemer F, Reaven GM: Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics and plasma triglyceride levels in normotriglyceridemic man. Metabolism 30:165-71, 1981
228. Topping DL, Mayes PA: The immediate effects of insulin and fructose on the metabolism of the perfused liver. Biochem J 126:295-311, 1972
229. Reaven GM: Non-insulin dependent diabetes mellitus, abnormal lipoprotein metabolism, and atherosclerosis. Metabolism 36 (Suppl. 1):1-8, 1987
230. Kissebah AH, Adams PW, Wynn V: Inter-relationship between insulin secretion and plasma free fatty acid and triglyceride transport kinetics in maturity onset diabetes and the effect of phenethylbiguanide (Phenformin). Diabetologia 10:119-30, 1974
231. Orchard TJ, Becker DJ, Bates M: Plasma insulin and lipoprotein cholesterol concentrations: an atherogenic association? Am J Epidemiol 118:326-37, 1983
232. Burke CL, Webber LS, Srinivasan SR: Fasting plasma glucose and insulin levels and their relationship to cardiovascular risk factors in children: Bogalusa. Metabolism 35:441-46, 1986
233. Garcia-Webb P, Bosner AM, Whitting D: Insulin resistance: a risk factor for coronary heart disease? Scand J Clin Lab Invest 43:677-85, 1983
234. Haffner SM, Fong D, Hazuda HP, Pugh JA, Patterson JK: Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics. Metabolism 37:338-45, 1988
235. Taskinen MR: Lipoprotein lipase in diabetes. Diabetes Metab Rev 3:551-70, 1987
236. Taskinen MR, Nikkila EA, Kuusi T: Lipoprotein lipase activity and serum lipoproteins in untreated type 2 (insulin-independent) diabetes associated with obesity. Diabetologia 22:46-50, 1982
237. Brunzell JD, Porte D, Bierman EL: Abnormal lipoprotein lipase mediated plasma triglyceride removal in untreated diabetes mellitus associated with hypertriglyceridemia. Metabolism 28:901-907, 1979
238. The Expert Panel: Report of the national cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med 148:36-69, 1988
239. Nikkilä EA: High density lipoproteins in diabetes. Diabetes 30 (Suppl. 2):82-87, 1981
240. Reckless JPD, Betterridge DJ, Wu P, Payne B, Gallon DJ: High-density and low-density lipoproteins and prevalence of vascular disease in diabetes mellitus. Br Med J 1:883-86, 1978
241. Welborn TA, Knuiman M, McCann V, Stanton K, Constable IJ: Clinical macrovascular disease in caucasoid diabetic subjects: logistic regression analysis of risk variables. Diabetologia 27:568-73, 1984
242. Fuh MM-T, Shieh S-M, Wu D-A, Chen Y-DI, Reaven GM: Abnormalities of carbohydrate and lipid metabolism in patients with hypertension. Arch Intern Med 147:1035-38, 1987
243. Haffner SM, Stern MP, Hazuda HP, Pugh J, Patterson JK: Do upper-body and centralized adiposity measure different aspects of regional body-fat distribution? Relationship to non-insulin-dependent diabetes mellitus, lipids, and lipoproteins. Diabetes 36:43-51, 1987
244. Stalder M, Pometta B, Suenram A: Relationship between plasma insulin levels and high density lipoprotein cholesterol levels in healthy men. Diabetologia 21:544-48, 1981
245. Zavaroni I, Dall'Aglio E, Alpi O, Bruschi F, Bonora E, Pezzarossa A, Butturini V: Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride. Atherosclerosis 55:259-66, 1985
246. Golay A, Zech L, Shi MZ, Chiou Y-AM, Reaven GM, Chen Y-DI: High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL. J Clin Endocrinol Metab 65:512-18, 1987
247. Cullen K, Stenhouse NS, Wearne KL, Welborn TA: Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia: 13 year study. J Chronic Dis 36:371-77, 1983
248. Jarrett RJ: Is insulin atherogenic? Diabetologia 31:71-75, 1988
249. Eschwege E, Richard JL, Thibult N, Ducimetiere P, Warnet JM, Claude JR, Rosselin GE: Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels: the Paris prospective study, ten years later. Horm Metab Res 15 (Suppl.):41-46, 1985
250. Welborn TA, Wearne K: Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 2:154-60, 1979
251. Ducimetiere P, Eschwege R, Papoz L, Richard JL, Claude JR, Rosselin G: Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 19:205-10, 1980
252. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H: Coronary-heart-disease risk and impaired glucose tolerance: the Whitehall study. Lancet 1:1373-76, 1980
253. Stern MP, Haffner SM: Body fat distribution and hyper-insulinemia as risk factors for diabetes and cardiovascular disease. Arteriosclerosis 6:123-30, 1986
254. Pyörälä K: Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 2:131-41, 1979
255. Pyörälä K, Uusitupa M, Laakso M, Siitonen O, Niskanen L, Ronnemaa T: Macrovascular complications in relation to hyperinsulinaemia in non-insulin-dependent diabetes mellitus. Diabete Metab 13:345-49, 1987
256. Ross R: The pathology of atherosclerosis: an update. N Engl J Med 314:488-500, 1986
257. Stout RW, Bierman EL, Ross A: Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells. Circ Res 36:319-27, 1975
258. Larson DM, Haudenschild CC: Activation of smooth muscle cell outgrowth from BB/Wor rat aortas. Diabetes 37:1380-85, 1988
259. Capron L, Jarnet J, Kazandjian S, Housset E: Growth-promoting effects of diabetes and insulin on arteries. Diabetes 35:973-78, 1986
260. Oppenheimer MJ, Sundquist K, Bierman EL: Downregulation of high-density lipoprotein receptor in human fibroblasts by insulin and IGF-I. Diabetes 38:117-22, 1989
261. Nakao J, Ito H, Kanayasu T, Murota S-I: Stimulatory effect of insulin on aortic smooth muscle cell migration induced by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid and its modulation by elevated extracellular glucose levels. Diabetes 34:185-91, 1985
262. Krone W, Greten H: Evidence for post-transcriptional regulation by insulin of 3-hydroxy-3-methylglutaryl coenzyme A reductase and sterol synthesis in human mononuclear leucocytes. Diabetologia 26:366-69, 1984
263. Stout R: Insulin stimulation of cholesterol synthesis by arterial tissue. Lancet 2:467-68, 1969
264. Stout RW: The effect of insulin on the incorporation of (1-C) sodium acetate into the lipids of the rat aorta. Diabetologia 7:367-72, 1971
265. Krone W, Naegele H, Behnke B, Greten H: Opposite effects of insulin and catecholamines on LDL-receptor activity in human mononuclear leukocytes. Diabetes 37:1386-91, 1988
266. Falholt K, Cutfield R, Alejandro R, Heding L, Mintz D: The effects of hyperinsulinemia on arterial wall and peripheral muscle metabolism in dogs. Metabolism 34:1146-49, 1985
267. Falholt K, Alberti KGMM, Hedwig L: Aorta and muscle metabolism in pigs with peripheral hyperinsulinemia. Diabetologia 28:32-37, 1985
268. Stamler J, Pick R, Katz LN: Effect of insulin in the induction and regression of atherosclerosis in the chick. Circ Res 8:572-76, 1960
269. Nordestgaard BG, Zilversmit DB: Large lipoproteins are excluded from the arterial wall in diabetic cholesterolfed rabbits. J Lipid Res 29:1491-500, 1988
270. Weiss RE, Reddi AH: Influence of experimental diabetes and insulin on matrix-induced cartilage and bone differentiation. Am J Physiol 238:E200-207, 1980
271. Hock JM, Centrella M, Canalis E: Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology 122:254-60, 1988
272. Veterans Administration Cooperative Study Group on antihypertensive agents: Effects of treatment on morbidity in hypertension. JAMA 213:1143-52, 1970
273. Medical Research Council Working Party: MRC trial of treatment of mild hypertension: principal results. Br Med J 291:97-104, 1985
274. Wikstrand J, Warnold I, Olsson G: Primary prevention with metoprolol in patients with hypertension: mortality results from the MAPHY study. JAMA 259:1976-82, 1988
275. Moster M, Sheps S: Confusing messages from the newest of the beta-blocker/diuretic hypertension trials: the metoprolol atherosclerosis prevention in hypertensives trial. Arch Intern Med 149:2174-75, 1989
276. MacMahon S, Cutler JA, Stamler J: Antihypertensive drug treatment: potential, expected, and observed effects on stroke and on coronary heart disease. Hypertension 13 (Suppl. I):45-50, 1989
277. Chait A: Effects of antihypertensive agents on serum lipids and lipoproteins. Am J Med 86 (Suppl. 1B):5-7, 1989
278. Ames RP: The influence of non-beta-blocking drugs on the lipid profile: are diuretics outclassed as initial therapy for hypertension? Am Heart J 114:998-1006, 1987
279. Weinberger MH: Antihypertensive therapy and lipids: paradoxical influences on cardiovascular disease risk. Am J Med 80 (Suppl. 2A):64-70, 1986
280. Frishman WH: Beta-adrenergic receptor blockers: adverse effects and drug interactions. Hypertension 11 (Suppl. II):21-29, 1988
281. Weinberger MH: Diuretics and their side effects: dilemma in the treatment of hypertension. Hypertension 11 (Suppl. II): 16-20, 1988
282. DeFronzo RA: Glucose intolerance and aging: evidence for tissue insensitivity to insulin. Diabetes 28:1095-101, 1979
283. DeFronzo RA: Glucose intolerance and aging. Diabetes Care 4:493-501, 1981
284. Fuller JH: Epidemiology of hypertension associated with diabetes mellitus. Hypertension 7 (Suppl. II):3-9, 1985
285. Barrett-Connor E, Criqui MH, Klauber MR, Holdbrook M: Diabetes and hypertension in a community of older adults. Am J Epidemiol 113:276-84, 1981
286. Koivisto V, DeFronzo RA: Physical training and insulin sensitivity. Diabetes Metab Rev 1:445-81, 1986
287. DeFronzo RA, Ferrannini E, Koivisto V: New concepts in the pathogenesis and treatment of non-insulin-dependent diabetes mellitus. Am J Med 73:52-81, 1983
288. Kemmer FW, Berger M: Therapy and better quality of life: the dichotomous role of exercise in diabetes. Diabetes Metab Rev 2:53-68, 1986
289. Physician's Guide to Non-Insulin-Dependent (Type II) Diabetes: Diagnosis and Treatment. 2nd ed. Rifkin H, Ed. Alexandria, VA, Am. Diabetes Assoc., 1988
290. Simonson DC, Ferrannini E, Bevilacqua S, Smith D, Barrett E, Carlson R, DeFronzo RA: Mechanism of improvement in glucose metabolism after chronic glyburide therapy. Diabetes 33:838-45, 1984
291. Mandarino LJ, Gerich JE: Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues. Diabetes Care 7 (Suppl. 1):89-99, 1984
292. Rosenstock J, Raskin P: Diabetes and its complications: blood glucose control versus genetic susceptibility. Diabetes Metab Rev 4:417-35, 1988
293. American Diabetes Association: Blood glucose control in diabetes. Diabetes 25:237-38, 1976
294. Ward WK, Beard JC, Porte D: Clinical aspects of islet beta-cell function in non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 2:297-313, 1986
295. Foley J, Kashiwagi A, Verso MA, Reaven G, Andrews J: Improvement in in vitro insulin action after one month of insulin therapy in obese noninsulin-dependent diabetics. J Clin Invest 72:1901-909, 1983
296. Andrews WJ, Vasquez B, Nagulesparan M, Klimes I, Foley J, Unger R, Reaven GM: Insulin therapy in obese, non-insulin-dependent diabetes induces improvements in insulin action and insulin secretion that are maintained for two weeks after insulin withdrawal. Diabetes 33:634-42, 1984
297. Bengtsson C, Blohme G, Lapidus L, Linquist O, Lundgren H, Nystrom E, Peterson K, Sigurdsson JA: Do antihypertensive drugs precipitate diabetes? Br Med J 289:1495-97, 1984
298. Skarfors ET, Lithell HO, Selinus I, Aber H: Do antihypertensive drugs precipitate diabetes in predisposed men? Br Med J 298:1147-51, 1989
299. Pollare T, Lithell H, Berne C: A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 321:868-73, 1989
300. Pollare T, Lithell H, Morlin C, Prantare H, Hvarfner A, Ljunghall S: Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups. J Hypertens 7:551-59, 1989
301. Swislocki ALM, Hoffman BB, Reaven GM: Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens 2:419-23, 1989
302. Pollare T, Lithell H, Selinus I, Berne C: Sensitivity to insulin during treatment with atenolol and metoprolol: a randomized double blind study of the effects on carbohydrate and lipoprotein metabolism in hypertensive patients. Br Med J 298:1152-57, 1989
303. Fleckenstein A, Fleckenstein-Grun G, Frey M, Zorn J: Calcium antagonism and ACE inhibition: two outstandingly effective means of interference with cardiovascular calcium overload, high blood pressure, and arteriosclerosis in spontaneously hypertensive rats. Am J Hypertens 2:194-204, 1989
304. Houston MC: The effects of antihypertensive drugs on glucose intolerance in hypertensive nondiabetics and diabetics. Am Heart J 115:640-56, 1988
305. Ferriere M, Lachkar H, Richard JL, Bringer J, Orsetti A, Mirouze J: Captopril and insulin sensitivity. Ann Intern Med 102:134-35, 1985
306. Dietze GJ, Rett K, Wicklmayr M, Jauch KW, Hartl W., Guenther B: Effects of antihypertensive treatment on glucose metabolism. In New Frontiers in Cardiovascular Therapy: Focus on ACE Inhibitors. Sonneblick E, Laragh J, Lesch M, Eds. Amsterdam, Excerpta Med., 1989, p. 350-61
307. Rett K, Jauch KW, Wicklmayr M, Dietze G, Fink E, Mehnert H: Angiotensin converting enzyme inhibitors in diabetes: experimental and human experience. Postgrad Med J 62 (Suppl. 1):59-64, 1986